Researcher
Dr. Anabel Torrente López
DETAILS
- Research
Analysis of glycoproteins and released glycans by different mass spectrometry approaches and LC-MS method development.
CURRICULUM VITAE
2024-Present | Postdoctoral researcher | Center for Proteomics and Metabolomics (CPM), Leiden University Medical Center (LUMC), Netherlands
2023-2024 | Postdoctoral researcher | Analysis of biopharmaceuticals | Department of Analytical Chemistry, University of Granada, Spain
2019-2023 | PhD in Pharmacy | Analysis of biopharmaceuticals by different analytical techniques and methodologies (LC-MS, DLS, CD, ELISA, etc.) | Department of Analytical Chemistry, University of Granada, Spain
2018-2019 | MSc. Research, Development, Control and Innovation of Medicines | University of Granada, Spain
2013-2018 | BSc. Pharmacy | University of Granada, Spain
Publications
-
Comprehensive Physicochemical and Functional Analysis of Pembrolizumab Based on Controlled Degradation Studies: Impact on Antigen–Antibody Binding
Anabel Torrente-López; Jesús Hermosilla; Antonio Salmerón-García; José Cabeza; Adolfina Ruiz-Martínez; Natalia Navas
European Journal of Pharmaceutics and Biopharmaceutics, 2024, 194, 131-147, doi.org/10.1016/j.ejpb.2023.12.005
-
Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and Isoforms Identification of Intact Nivolumab
Anabel Torrente-López, Jesús Hermosilla, Raquel Pérez-Robles, Antonio Salmerón-García, José Cabeza, Natalia Navas
Microchemical Journal, 2022, 182, 107896, doi.org/10.1016/j.microc.2022.107896
-
Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress
Anabel Torrente-López; Jesús Hermosilla; Antonio Salmerón-García; José Cabeza; Natalia Navas
Pharmaceutics, 2022, 14 (4), 692, doi.org/10.3390/pharmaceutics14040692
Groups:
Proteoform Profiling
